For FTC and LabMD, a turning point is reached with no endgame in sight

28 Jul For FTC and LabMD, a turning point is reached with no endgame in sight

photo-1453945619913-79ec89a82c51-1
For FTC and LabMD, a turning point is reached with no endgame in sight (July 27, 2016) – LabMD Inc. CEO Michael Daugherty seems to be winning in the court of public opinion. Now all he has to do is win in federal court and at the Federal Trade Commission. For cybersecurity pros, the more important decision is the one the FTC is due to make July 28 after its original June 16 deadline was delayed “to give full consideration of the issues presented.” In the first FTC data breach case to go this far without settling, as some 60 other companies have done over the years, LabMD is challenging whether a minor data leak of dubious origins that led to no consumer harm is subject to the FTC’s authority.

Read more below:

 

MimFor FTC and LabMD, a turning point is reached with no endgame in sighte Attachment

Credit: Congressional Roll Call

Michael Daugherty
mdort@aol.com

Michael Daugherty is President & CEO of LabMD, an Atlanta-based clinical and anatomic medical laboratory with a national client base. Mike founded LabMD in 1996 after 14 years in surgical device sales with U.S. Surgical Corp. and Mentor Corporation.

Outside of LabMD, enjoys playing tennis, travel, and flying his Cirrus SR22 Turbo single engine aircraft.